GlassScriptPhysician profile
Joseph Helak
NPI 1609888569
$1,668.96
in general payments reported to CMS, 2019-2025
19 companies · $144 in 2025
The $144 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,081 · 2020: $274 · 2021: $156 · 2024: $13.51 · 2025: $144.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $158.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $157.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $567.18 | 2019-2021 | |
| Amgen INC. | $215.82 | 2019-2020 | |
| Pfizer INC. | $199.09 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $156.28 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $106.10 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $60.08 | 2025 | |
| Ge Healthcare | $51.74 | 2020 | |
| Novartis Pharmaceuticals Corporation | $50.76 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $41.17 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $38.48 | 2019-2021 | |
| Amarin Pharma, INC. | $34.18 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $26.38 | 2019 | |
| Atricure, INC. | $24.54 | 2025 | Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System, Atricure Cryoice Cryosphere Cryoablation System |
| Corvista Health, INC. | $22.67 | 2025 | Corvista System |
| Novo Nordisk INC | $22.06 | 2025 | Wegovy |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $14.84 | 2025 | Verquvo |
| Vital Connect, INC | $13.51 | 2024 | Vitalpatch Rtm |
| Portola Pharmaceuticals, LLC | $12.08 | 2019 | |
| Bardy Diagnostics, INC. | $12.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Helak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.